By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Sorrento Therapeutics, Inc. 

6042 Cornerstone Court W,

San Diego  California  92121  U.S.A.
Phone: n/a Fax: n/a



Company News
Sorrento To Present At The 2015 Jefferies and Co. Healthcare Conference And At Other Conferences 5/26/2015 10:12:41 AM
Advaxis, Inc. And Sorrento Form Collaboration To Evaluate Combinations Of Advaxis's Lm-LLO Immunotherapy Technology And Sorrento's Immunomodulatory Antibodies 5/19/2015 8:20:15 AM
Sorrento Establishes TNK Therapeutics Subsidiary With Focus On Cellular Immunotherapies 5/18/2015 7:23:14 AM
Patrick Soon-Shiong's NantPharma Snaps Up Rights to Sorrento's Cynviloq in Deal Worth $1.3 Billion+ 5/15/2015 7:26:09 AM
Sorrento Therapeutics, Inc. Shows Off Positive TRIBECA Registrational Study Results 5/4/2015 7:21:35 AM
Sorrento Therapeutics, Inc. Acquires South American Rights To Cynviloq 5/1/2015 11:41:38 AM
Sorrento Therapeutics, Inc. Announces The Appointments Of David H. Deming To The Board Of Directors And Mark W. Durand As Chief Financial Officer 5/1/2015 7:38:55 AM
Sorrento Therapeutics, Inc. Announces Three Preclinical Poster Presentations On Cynviloq, Its Novel Antibody Drug Conjugate Linker Technology And C-Met/EGFR Bispecific ADC At The 106th Annual Meeting Of The AACR 4/20/2015 1:25:27 PM
Sorrento Therapeutics, Inc. To Present At Jefferies and Co. 2015 Immuno-Oncology Summit 4/13/2015 8:03:45 AM
Sorrento Therapeutics, Inc. Announces Appointment Of George Ng As EVP & Chief Legal Officer 3/30/2015 12:14:55 PM